Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Astermark

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 19, 2014
Switching clotting factor concentrates: considerations in estimating the risk of immunogenicityD Matino, D Lillicrap, J Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitorsJ Astermark, A Rocino, M Von Depka, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 20, 2009
European curriculum for thrombosis and haemostasisJ Astermark, C Negrier, C Hermans, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2012
F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined CohortJ Schwarz, J Astermark, E D Menius, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2010
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus reportJ Astermark, C Altisent, A Batorova, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2017
Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: results of the INSIGHT case-control studyA S van Velzen, C L Eckhardt, M Peters, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conferenceE Berntorp, A Shapiro, J Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2002
Unresolved issues in prophylaxisS A Brown, L M Aledort, J Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 2003
Consensus perspectives on prophylactic therapy for haemophilia: summary statementE Berntorp, J Astermark, S Björkman, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 19, 2014
Switching clotting factor concentrates: considerations in estimating the risk of immunogenicityD Matino, D Lillicrap, J Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitorsJ Astermark, A Rocino, M Von Depka, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 20, 2009
European curriculum for thrombosis and haemostasisJ Astermark, C Negrier, C Hermans, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 11, 2012
F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined CohortJ Schwarz, J Astermark, E D Menius, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2010
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus reportJ Astermark, C Altisent, A Batorova, et al.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2017
Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients: results of the INSIGHT case-control studyA S van Velzen, C L Eckhardt, M Peters, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 25, 2006
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conferenceE Berntorp, A Shapiro, J Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2002
Unresolved issues in prophylaxisS A Brown, L M Aledort, J Astermark, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 2003
Consensus perspectives on prophylactic therapy for haemophilia: summary statementE Berntorp, J Astermark, S Björkman, et al.
Pageof 8